Cytokinetics clinical trial
WebJan 1, 2016 · A clinically significant illness within 4 weeks of Screening History of alcoholism or drug addiction within 2 years prior to Screening History of smoking more than 10 cigarettes (or equivalent amount of tobacco) per day within 3 months prior to Screening WebMay 19, 2024 · Known to have received CK-2127107 or tirasemtiv in any previous clinical trial; ... Cytokinetics: ClinicalTrials.gov Identifier: NCT03160898 Other Study ID Numbers: CY 5022 : First Posted: May 19, 2024 Key Record Dates: Results First Posted: September 11, 2024: Last Update Posted: ...
Cytokinetics clinical trial
Did you know?
WebJun 17, 2024 · Cytokinetics is readying for the potential commercialization of omecamtiv mecarbil, its cardiac muscle activator, following positive results from GALACTIC-HF, a large, international Phase 3 clinical trial in patients with heart failure. WebMar 31, 2024 · Cytokinetics Muscle Biology Therapies Home empowering muscle empowering lives Cytokinetics is committed to our mission of developing potential medicines that may improve the …
WebA recent clinical trial of patients with Mullerian tumours has shown some response in tumour mitigation and reduction of the CA-125 (Roc he et al., 2010). Eubank et al. (2009) … WebOct 10, 2024 · A late-stage clinical trial testing an experimental ALS treatment from Cytokinetics, a Californian biotechnology company, will continue as planned following a review of preliminary results by an independent data monitoring committee. ... Cytokinetics aims to enroll 555 patients with ALS in its study, called COURAGE-ALS, and testing the …
WebJun 5, 2024 · Types of Cytokines. Cytokines are diverse and serve a number of functions in the body. They: Stimulate the production of blood cells. Aid in the development, … WebFeb 17, 2024 · Cytokinetics ( NASDAQ: CYTK) is a company dedicated to improving patient health and quality of life by developing muscle biology-based medications. Their lead drug candidate, omecamtiv mecarbil,...
WebApr 10, 2024 · Cytokinetics is developing aficamten, a next-in-class cardiac myosin inhibitor, currently the subject of SEQUOIA-HCM, the Phase 3 clinical trial of aficamten …
WebJun 24, 2024 · SOUTH SAN FRANCISCO, Calif., June 24, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and Drug Administration (FDA) has informed the company... iron chef america chefs 9WebCytokinetics is developing omecamtiv mecarbil, a novel, selective cardiac myosin activator for the potential treatment for heart failure with reduced ejection fraction (HFrEF). Omecamtiv mecarbil stimulates cardiac … port number informationWebApr 10, 2024 · Examples of such statements include, but are not limited to, statements relating to Cytokinetics' and its partners' research and development activities of Cytokinetics’ product candidates, including the potential commencement of a Phase 3 clinical trial of aficamten in patients with nonobstructive hypertrophic cardiomyopathy in … iron chef america chsWebJan 7, 2024 · Cytokinetics Investigators More Information Go to Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number): Zampieri M, Argiro A, Marchi A, Berteotti M, Targetti M, Fornaro A, Tomberli A, Stefano P, Marchionni N, Olivotto I. Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy. iron chef america chefs nameWebMar 31, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential... iron chef america chefs llWebApr 10, 2024 · Cytokinetics is developing aficamten, a next-in-class cardiac myosin inhibitor, currently the subject of SEQUOIA-HCM, the Phase 3 clinical trial of aficamten in patients with symptomatic ... iron chef america chefs names in oWebMay 5, 2024 · We have conducted more than 50 clinical trials as we strive to bring important new medicines to patients with diseases like ALS, heart failure, HCM and SMA. Company Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Our Vision Leadership … iron chef america chefs names in